Article
A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma
30 Oct 2015
Abstract excerpt
Clear cell renal cell carcinomas (ccRCCs) display divergent clinical behaviours. Molecular markers might improve risk stratification of ccRCC. Here we use, based on genome-wide CpG methylation profiling, a LASSO model to develop a five-CpG-based assay for ccRCC prognosis that can be used with formalin-fixed paraffin-embedded specimens. The five-CpG-based classifier was validated in three independent sets from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
